Epigenomics AG Sustainability Reports
Epigenomics AG is a molecular diagnostics company specializing in the development of blood-based tests for the early detection of cancer.
Sector: Health Care
Country: Germany
Exchange: Frankfurt Stock Exchange
ISIN: DE000A37FT41
29 reports from 2007 to 2025
Company Profile
Epigenomics AG
Epigenomics AG is a molecular diagnostics company specializing in the development of blood-based tests for the early detection of cancer.
Reports